Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
boston top stories
indiana blog main
5
×
indiana top stories
life sciences
national blog main
national top stories
5
×
novartis
5
×
roche
5
×
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
national
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
immunotherapy
medicare
president trump
spark therapeutics
abbvie
alexion pharmaceuticals
alzheimer's disease
biogen
What
drug
bio
latest
roundup
patients
plan
acquisitions
address
advantages
albert
alzheimer’s
american
annual
approval
approves
ash
bar
biggest
blood
blueprint
borne
bourla
brings
cancer
cancers
carries
ceo
certain
companies
company
conference
crispr
designed
diego
different
expect
fail
fda
future
gamble
Language
unset
unknown
Current search:
biotech
×
novartis
×
roche
×
" national top stories "
×
" indiana blog main "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More